Bausch Health Companies Inc VRX:Swiss Exchange

*Data is delayed | Exchange | CHF
Last | 06/28/19 CEST
24.11UNCH (UNCH)
52 week range
0.00 - 24.11
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close24.11
  • 52 Week High24.11
  • 52 Week High Date06/28/19
  • 52 Week Low0.00
  • 52 Week Low Date-

Key Stats

  • Market Cap2,491.22M
  • Shares Out360.99M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close24.11
  • 52 Week High24.11
  • 52 Week High Date06/28/19
  • 52 Week Low0.00
  • 52 Week Low Date-
  • Market Cap2,491.22M
  • Shares Out360.99M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Bausch Health Companies Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures, and markets a range of products primarily in gastroenterology (GI), hepatology, neurology, dermatology, eye health, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with the exception of sales of Bausch + Lomb products and Solta Medical aesthetic...
John Paulson
Independent Chairman of the Board
Thomas Appio
Chief Executive Officer, Director
John Barresi
Interim Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Controller
Seana-Lyn Carson
Executive Vice President, General Counsel
Address
2150 Saint-Elzear Blvd W
Laval, QC
H7L 4A8
Canada